Morpholino

MO2-mgaa

ID

ZDB-MRPHLNO-100426-2

Name

MO2-mgaa

Previous Names

Target

Sequence

5' - AACTCAGTCTGAGCAAAACTGAGAG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Targets sequences +746–770 relative to the initiation ATG. The target site is not an exon-intron junction, but lies fully within the first exon.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-mgaa

No data available

Phenotype

Phenotype resulting from MO2-mgaa

Phenotype	Fish	Figures
ball size, abnormal	WT + MO2-mgaa	text only from Rikin et al., 2010
blood nucleate erythrocyte decreased amount, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
brain apoptotic, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
extension degenerate, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
eye decreased size, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
forebrain midbrain boundary amorphous, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
heart looping disrupted, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
hindbrain aplastic, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
hindbrain edematous, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
integument colorless, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
midbrain hindbrain boundary amorphous, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
pericardium edematous, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010
whole organism dead, abnormal	WT + MO2-mgaa	text only from Rikin et al., 2010
whole organism decreased size, abnormal	WT + MO2-mgaa	Fig. 3 from Rikin et al., 2010

Phenotype of all Fish created by or utilizing MO2-mgaa

Phenotype	Fish	Conditions	Figures
midbrain hindbrain boundary amorphous, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
heart looping disrupted, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
blood nucleate erythrocyte decreased amount, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
whole organism decreased size, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
forebrain midbrain boundary amorphous, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
hindbrain aplastic, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
whole organism dead, abnormal	WT + MO2-mgaa	standard conditions	text only from Rikin et al., 2010
extension degenerate, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
eye decreased size, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
hindbrain edematous, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
integument colorless, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
brain apoptotic, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
pericardium edematous, abnormal	WT + MO2-mgaa	standard conditions	Fig. 3 from Rikin et al., 2010
ball size, abnormal	WT + MO2-mgaa	standard conditions	text only from Rikin et al., 2010

Citations